Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 6 (June)

1. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly.
   Pathol Int, 57(6): 303-14. [Abstract] [Full-text]
2. Searchable high-resolution 2D gel proteome of the human colon crypt.
   J Proteome Res, 6(6): 2232-8. [Abstract] [Full-text]
3. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males.
   Dis Colon Rectum, 50(5): 565-75. [Abstract] [Full-text]
4. Function and quality of life after transanal excision of rectal polyps and cancers.
   Dis Colon Rectum, 50(5): 598-603. [Abstract] [Full-text]
5. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
   Dis Colon Rectum, 50(5): 611-20. [Abstract] [Full-text]
6. Screening for colorectal cancer in average-risk Chinese population using a mixed strategy with sigmoidoscopy and colonoscopy.
   Dis Colon Rectum, 50(5): 630-40. [Abstract] [Full-text]
7. Minute depressed-type submucosal invasive cancer-5 mm in diameter with intermediate lymph-node metastasis: report of a case.
   Dis Colon Rectum, 50(5): 677-81. [Abstract] [Full-text]
8. Long-term outcome after operative intervention for rectal cancer in patients aged over 80 years: analysis of 9,501 patients.
   Dis Colon Rectum, 50(5): 604-10. [Abstract] [Full-text]
9. The impact of the largest metastasis size on nodal tumor burden in colorectal carcinomas: implications for the sentinel lymph node theory in cancers of the large intestine.
   J Surg Oncol, 95(8): 629-34. [Abstract] [Full-text]
10. Perineal colostomy with appendicostomy as an alternative for an abdominal colostomy: symptoms, functional status, quality of life, and perceived health.
    Dis Colon Rectum, 50(6): 817-24. [Abstract] [Full-text]
11. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
    J Surg Oncol, 95(8): 652-62. [Abstract] [Full-text]
12. The clinical and endoscopic characteristics, treatment, and long-term prognosis of early colorectal cancer in Taiwan.
    Dis Colon Rectum, 50(6): 856-60. [Abstract] [Full-text]
13. Complications and sexual function after vaginectomy for anorectal tumors.
    Dis Colon Rectum, 50(6): 810-6. [Abstract] [Full-text]
14. Patient satisfaction and health-related quality of life after treatment for colon cancer.
    Dis Colon Rectum, 50(6): 801-9. [Abstract] [Full-text]
15. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
    Int J Radiat Oncol Biol Phys, 68(3): 794-800. [Abstract] [Full-text]
16. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.
    Int J Radiat Oncol Biol Phys, 68(3): 830-8. [Abstract] [Full-text]
17. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
    Cell Signal, 19(7): 1465-72. [Abstract] [Full-text]
18. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells.
    Biochem Biophys Res Commun, 359(1): 102-7. [Abstract] [Full-text]
19. Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imaging.
    Am J Clin Oncol, 30(3): 315-8. [Abstract] [Full-text]
20. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    JAMA, 297(21): 2351-9. [Abstract] [Full-text]
21. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry.
    J Med Genet, 44(6): 404-7. [Abstract] [Full-text]
22. Prospective study on bright lumen magnetic resonance colonography in comparison with conventional colonoscopy.
    Br J Radiol, 80(952): 235-41. [Abstract] [Full-text]
23. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).
    J Med Genet, 44(6): 353-62. [Abstract] [Full-text]
24. Variation of mesorectal volume with abdominal fat volume in patients with rectal carcinoma: assessment with MRI.
    Br J Radiol, 80(952): 242-7. [Abstract] [Full-text]
25. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf.
    Bioorg Med Chem, 15(14): 4923-32. [Abstract] [Full-text]
26. Computed tomographic colonography for colorectal screening.
    Endoscopy, 39(6): 545-9. [Abstract] [Full-text]
27. The feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study.
    Endoscopy, 39(6): 521-4. [Abstract] [Full-text]
28. Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients.
    Eur J Cancer Prev, 16(4): 298-303. [Abstract] [Full-text]
29. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
    Eur J Cancer Prev, 16(4): 292-7. [Abstract] [Full-text]
30. Diet and vitamin or mineral supplementation and risk of colon cancer by subsite in Canada.
    Eur J Cancer Prev, 16(4): 275-91. [Abstract] [Full-text]
31. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
    Expert Rev Anticancer Ther, 7(6): 887-97. [Abstract] [Full-text]
32. Capecitabine in the treatment of colorectal cancer.
    Expert Rev Anticancer Ther, 7(6): 803-10. [Abstract] [Full-text]
33. The developing trend of monoclonal antibodies in the treatment of colorectal cancer.
    Expert Opin Biol Ther, 7(6): 871-83. [Abstract] [Full-text]
34. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells.
    Toxicol Appl Pharmacol, 221(3): 261-7. [Abstract] [Full-text]
35. Surgical management of rectal cancer.
    Semin Oncol, 34(3): 241-9. [Abstract] [Full-text]
36. Mesenteric plexiform neurofibroma in an 11-year-old boy with von Recklinghausen disease.
    J Pediatr Surg, 42(6): E15-8. [Abstract] [Full-text]
37. Case control study of the geographic variability of exposure to disinfectant byproducts and risk for rectal cancer.
    Int J Health Geogr, 6: 18. [Abstract] [Full-text]
38. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
    Cancer, 109(12): 2410-9. [Abstract] [Full-text]
39. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
    J Pathol, 212(3): 260-8. [Abstract] [Full-text]
40. Improved systemic pharmacokinetics, biodistribution, and antitumor activity of CpG oligodeoxynucleotides complexed to endogenous antibodies in vivo.
    J Control Release, 120(1): 95-103. [Abstract] [Full-text]
41. Signet ring cell differentiation in mucinous colorectal carcinoma.
    J Pathol, 212(3): 278-86. [Abstract] [Full-text]
42. Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas.
    J Pathol, 212(3): 269-77. [Abstract] [Full-text]
43. A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer.
    Expert Opin Pharmacother, 8(9): 1313-28. [Abstract] [Full-text]
44. Risk of colorectal cancer in juvenile polyposis.
    Gut, 56(7): 965-7. [Abstract] [Full-text]
45. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
    Gut, 56(7): 926-33. [Abstract] [Full-text]
46. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Oncogene, 26(28): 4049-58. [Abstract] [Full-text]
47. Body mass and colorectal cancer risk in the NIH-AARP cohort.
    Am J Epidemiol, 166(1): 36-45. [Abstract] [Full-text]
48. Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 60(3): 383-9. [Abstract] [Full-text]
49. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 60(3): 351-6. [Abstract] [Full-text]
50. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses.
    Gastroenterology, 132(7): 2459-77. [Abstract] [Full-text]
51. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
    Gastroenterology, 132(7): 2448-58. [Abstract] [Full-text]
52. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
    Gastroenterology, 132(7): 2304-12. [Abstract] [Full-text]
53. Factors associated with incomplete colonoscopy: a population-based study.
    Gastroenterology, 132(7): 2297-303. [Abstract] [Full-text]
54. Routine preoperative abdominal computed tomography in colon cancer: a utility study.
    Tech Coloproctol, 11(2): 105-9. [Abstract] [Full-text]
55. Accuracy of digital rectal examination in the estimation of height of rectal lesions.
    Tech Coloproctol, 11(2): 111-3. [Abstract] [Full-text]
56. Rectal bleeding and previous anticoagulant treatment in patients with colorectal cancer do not predict outcome.
    Tech Coloproctol, 11(2): 121-6; discussion 126-7. [Abstract] [Full-text]
57. Mucinous adenocarcinoma derived from chronic perianal fistulas: report of a case and review of the literature.
    Tech Coloproctol, 11(2): 155-7. [Abstract] [Full-text]
58. Development of a new Ca2+/calmodulin antagonist and its anti-proliferative activity against colorectal cancer cells.
    Biochem Biophys Res Commun, 359(3): 747-51. [Abstract] [Full-text]
59. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells.
    Biochem Biophys Res Commun, 359(3): 568-73. [Abstract] [Full-text]
60. Insulinlike growth factor I receptor and estrogen receptor beta expressions are inversely correlated in colorectal neoplasms and affected by the insulin resistance syndrome.
    Hum Pathol, 38(7): 1037-46. [Abstract] [Full-text]
61. Increased pontin expression in human colorectal cancer tissue.
    Hum Pathol, 38(7): 978-85. [Abstract] [Full-text]
62. Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist.
    J Clin Oncol, 25(18): 2573-9. [Abstract] [Full-text]
63. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases.
    Arch Surg, 142(6): 526-31; discussion 531-2. [Abstract] [Full-text]
64. Oral and maxillofacial manifestations of familial adenomatous polyposis.
    Oral Dis, 13(4): 360-5. [Abstract] [Full-text]
65. Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
    BMC Cancer, 7: 91. [Abstract] [Full-text]
66. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.
    Ann Thorac Surg, 84(1): 324-38. [Abstract] [Full-text]
67. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer.
    Ann Thorac Surg, 84(1): 203-10. [Abstract] [Full-text]
68. Dietary fiber and colorectal cancer risk: the multiethnic cohort study.
    Cancer Causes Control, 18(7): 753-64. [Abstract] [Full-text]
69. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer.
    Cancer Causes Control, 18(7): 723-33. [Abstract] [Full-text]
70. Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors.
    Cancer Causes Control, 18(7): 735-42. [Abstract] [Full-text]
71. The AFC score: validation of a 4-item predicting score of postoperative mortality after colorectal resection for cancer or diverticulitis: results of a prospective multicenter study in 1049 patients.
    Ann Surg, 246(1): 91-6. [Abstract] [Full-text]
72. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    Ann Surg, 246(1): 83-90. [Abstract] [Full-text]
73. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review.
    Ann Surg, 246(1): 24-30. [Abstract] [Full-text]
74. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
    Am J Gastroenterol, 102(7): 1489-98. [Abstract] [Full-text]
75. Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells.
    Bioorg Med Chem, 15(16): 5620-8. [Abstract] [Full-text]
76. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Eur Surg Res, 39(4): 245-50. [Abstract] [Full-text]
77. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Eur Surg Res, 39(4): 229-38. [Abstract] [Full-text]
78. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    BMC Med Genet, 8: 28. [Abstract] [Full-text]
79. A new variant database for mismatch repair genes associated with Lynch syndrome.
    Hum Mutat, 28(7): 669-73. [Abstract] [Full-text]
80. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.
    Oncogene, 26(30): 4435-41. [Abstract] [Full-text]
81. Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression.
    J Clin Pathol, 60(7): 781-6. [Abstract] [Full-text]
82. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.
    J Clin Pathol, 60(7): 768-72. [Abstract] [Full-text]
83. The role of chromoendoscopy in the surveillance of the duodenum of patients with familial adenomatous polyposis.
    Dig Dis Sci, 52(8): 1906-9. [Abstract] [Full-text]
84. Long-term immunity elicited by antibody-cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.
    Cancer Immunol Immunother, 56(9): 1507-12. [Abstract] [Full-text]
85. Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity.
    Cancer Immunol Immunother, 56(9): 1367-79. [Abstract] [Full-text]
86. Joint mapping of genes and conditions via multidimensional unfolding analysis.
    BMC Bioinformatics, 8: 181. [Abstract] [Full-text]
87. Dietary fatty acids and colorectal cancer: a case-control study.
    Am J Epidemiol, 166(2): 181-95. [Abstract] [Full-text]
88. Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP diet and health study.
    Am J Epidemiol, 166(2): 170-80. [Abstract] [Full-text]
89. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk.
    Am J Epidemiol, 166(2): 130-6. [Abstract] [Full-text]

© 2004-2010 Colorectal Cancer Research Today. All Rights Reserved.